• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

改良的主要肺切除相关心血管风险评分系统的验证。

Validation of a modified scoring system for cardiovascular risk associated with major lung resection.

机构信息

Department of Surgery, The University of Chicago, Chicago, IL 60637, USA.

出版信息

Eur J Cardiothorac Surg. 2012 Mar;41(3):598-602. doi: 10.1093/ejcts/ezr081. Epub 2011 Dec 1.

DOI:10.1093/ejcts/ezr081
PMID:22345181
Abstract

OBJECTIVES

The well-known revised cardiac risk index (RCRI) has recently been modified based on factors and outcomes specific to thoracic surgery patients (ThRCRI). We explored the accuracy of this modified scoring system in predicting cardiovascular morbidity after major lung resection.

METHODS

We analyzed outcomes from a prospective database of patients undergoing major lung resection 1980-2009. ThRCRI score was based on weighted factors for serum creatinine, coronary artery disease, cerebrovascular disease and extent of lung resection. Target adverse outcomes included pulmonary embolism, myocardial infarction, cardiac arrest, pulmonary edema and cardiac death.

RESULTS

A total of 1255 patients (mean age 61.8 years; 649 men) underwent lobectomy or bilobectomy (1070; 85%) or pneumonectomy (185; 15%) for cancer (1037; 83%) or other problems. Severe cardiovascular complications occurred in 30 patients (2.4%), an incidence similar to that in the published derivation group (3.3%). ThRCRI median scores in patients without and with severe CV complications were 0 and 1.5 (P < 0.001). Score categories yielded incremental risks of cardiovascular complications (0: 0.9%; 1-1.5: 4.5%; ≥ 2: 12.8%; P < 0.001). The Hosmer-Lemeshow test demonstrated no significant difference between expected and observed outcomes (P = 0.11).

CONCLUSIONS

The incidences of severe postoperative cardiovascular complications were similar in the published derivation group and the current validation group. The ThRCRI score successfully stratified risk for postoperative cardiovascular events after major lung resection in the validation group. The expected risk in the validation group was similar to the observed risk, indicating that ThRCRI accurately predicted specific risk rather than just relative risk. Further evaluation of the utility of this scoring system is warranted.

摘要

目的

最近,基于特定于胸外科患者的因素和结果,对著名的修订后的心脏风险指数(RCRI)进行了修改(ThRCRI)。我们探讨了该改良评分系统在预测大肺切除术后心血管发病率方面的准确性。

方法

我们分析了 1980 年至 2009 年接受大肺切除术的前瞻性数据库的结果。ThRCRI 评分基于血清肌酐、冠状动脉疾病、脑血管疾病和肺切除范围的加权因素。目标不良结局包括肺栓塞、心肌梗死、心脏骤停、肺水肿和心脏死亡。

结果

共有 1255 例患者(平均年龄 61.8 岁;649 例男性)接受了肺叶切除术或双肺叶切除术(1070 例;85%)或全肺切除术(185 例;15%),用于癌症(1037 例;83%)或其他问题。30 例(2.4%)患者发生严重心血管并发症,发生率与发表的推导组相似(3.3%)。无严重 CV 并发症和有严重 CV 并发症患者的 ThRCRI 中位数分别为 0 和 1.5(P < 0.001)。评分类别显示心血管并发症的风险逐渐增加(0:0.9%;1-1.5:4.5%;≥2:12.8%;P < 0.001)。Hosmer-Lemeshow 检验表明预期结果与观察结果无显著差异(P = 0.11)。

结论

在发表的推导组和当前的验证组中,严重术后心血管并发症的发生率相似。ThRCRI 评分成功地对验证组大肺切除术后心血管事件的风险进行了分层。验证组的预期风险与观察到的风险相似,表明 ThRCRI 准确预测了特定风险,而不仅仅是相对风险。进一步评估该评分系统的实用性是必要的。

相似文献

1
Validation of a modified scoring system for cardiovascular risk associated with major lung resection.改良的主要肺切除相关心血管风险评分系统的验证。
Eur J Cardiothorac Surg. 2012 Mar;41(3):598-602. doi: 10.1093/ejcts/ezr081. Epub 2011 Dec 1.
2
Prediction of major cardiovascular events after lung resection using a modified scoring system.改良评分系统预测肺切除术后主要心血管事件。
Ann Thorac Surg. 2014 Apr;97(4):1135-40. doi: 10.1016/j.athoracsur.2013.12.032. Epub 2014 Feb 22.
3
External validation of the recalibrated thoracic revised cardiac risk index for predicting the risk of major cardiac complications after lung resection.校正后的胸外科修订心脏风险指数在预测肺切除术后主要心脏并发症风险中的外部验证。
Ann Thorac Surg. 2011 Aug;92(2):445-8. doi: 10.1016/j.athoracsur.2011.03.095. Epub 2011 Jun 24.
4
Recalibration of the revised cardiac risk index in lung resection candidates.肺切除候选者中修订后的心脏风险指数的再校准。
Ann Thorac Surg. 2010 Jul;90(1):199-203. doi: 10.1016/j.athoracsur.2010.03.042.
5
Diffusing capacity predicts morbidity after lung resection in patients without obstructive lung disease.在无阻塞性肺疾病的患者中,弥散能力可预测肺切除术后的发病率。
Ann Thorac Surg. 2008 Apr;85(4):1158-64; discussion 1164-5. doi: 10.1016/j.athoracsur.2007.12.071.
6
Validating the Thoracic Revised Cardiac Risk Index Following Lung Resection.肺切除术后验证修订的胸段心脏风险指数
Ann Thorac Surg. 2017 Aug;104(2):389-394. doi: 10.1016/j.athoracsur.2017.02.006. Epub 2017 May 9.
7
A scoring system predicting the risk for intensive care unit admission for complications after major lung resection: a multicenter analysis.预测肺叶切除术后并发症入住重症监护病房风险的评分系统:一项多中心分析。
Ann Thorac Surg. 2008 Jul;86(1):213-8. doi: 10.1016/j.athoracsur.2008.03.063.
8
The impact of preoperative body mass index on respiratory complications after pneumonectomy for non-small-cell lung cancer. Results from a series of 154 consecutive standard pneumonectomies.术前体重指数对非小细胞肺癌肺切除术后呼吸系统并发症的影响。154 例标准肺切除术系列结果。
Eur J Cardiothorac Surg. 2011 May;39(5):738-44. doi: 10.1016/j.ejcts.2010.09.007. Epub 2010 Oct 16.
9
Incidence and risk factors for lung injury after lung cancer resection.肺癌切除术后肺损伤的发生率及危险因素
Ann Thorac Surg. 2007 Oct;84(4):1085-91; discussion 1091. doi: 10.1016/j.athoracsur.2007.05.053.
10
B-type natriuretic Peptide as a predictor of postoperative cardiopulmonary complications in elderly patients undergoing pulmonary resection for lung cancer.B 型利钠肽作为预测老年肺癌患者行肺切除术后心肺并发症的指标。
Ann Thorac Surg. 2011 Sep;92(3):1051-5. doi: 10.1016/j.athoracsur.2011.03.085.

引用本文的文献

1
Anesthetic considerations for lung resection: preoperative assessment, intraoperative challenges and postoperative analgesia.肺切除术的麻醉考量:术前评估、术中挑战及术后镇痛
Ann Transl Med. 2019 Aug;7(15):356. doi: 10.21037/atm.2019.03.67.
2
Factors Associated With Clinical Deterioration Among Patients Hospitalized on the Wards at a Tertiary Cancer Hospital.与在一家三级癌症医院的病房住院的患者临床恶化相关的因素。
J Oncol Pract. 2019 Aug;15(8):e652-e665. doi: 10.1200/JOP.18.00765. Epub 2019 Jul 15.
3
Necessity of the heart, for lung resection.
肺切除术中心脏的必要性。
J Thorac Dis. 2019 May;11(Suppl 9):S1132-S1134. doi: 10.21037/jtd.2019.04.72.
4
Transcatheter aortic valve implantation for patients with lung cancer and aortic valve stenosis.肺癌合并主动脉瓣狭窄患者的经导管主动脉瓣植入术
J Thorac Dis. 2018 May;10(5):E387-E390. doi: 10.21037/jtd.2018.04.83.
5
Preoperative functional workup for patients with advanced lung cancer.晚期肺癌患者的术前功能评估
J Thorac Dis. 2016 Nov;8(Suppl 11):S840-S848. doi: 10.21037/jtd.2016.03.73.
6
Risk Stratification in Lung Resection.肺切除术的风险分层
Curr Surg Rep. 2016;4(11):37. doi: 10.1007/s40137-016-0158-x. Epub 2016 Sep 20.
7
Surgery for non-small cell lung cancer in patients with a history of cardiovascular surgery.有心血管手术史的非小细胞肺癌患者的手术治疗
Surg Today. 2017 Mar;47(3):284-292. doi: 10.1007/s00595-016-1386-5. Epub 2016 Jul 21.
8
Does the revised cardiac risk index predict cardiac complications following elective lung resection?修订后的心脏风险指数能否预测择期肺切除术后的心脏并发症?
J Cardiothorac Surg. 2013 Dec 1;8:220. doi: 10.1186/1749-8090-8-220.
9
Surgical treatment of non-small-cell lung cancer in octogenarians.八旬老人非小细胞肺癌的外科治疗
Interact Cardiovasc Thorac Surg. 2013 May;16(5):673-80. doi: 10.1093/icvts/ivt020. Epub 2013 Feb 8.